Acquiring Company
Senores Pharmaceuticals
Acquired Company
Apnar Pharmaceuticals
CopenhagenDescription
Senores Pharmaceuticals has completed Phase 1 of the acquisition of a 75% equity stake in Apnar Pharmaceuticals. This strategic acquisition aims to strengthen Senores' footprint in the pharmaceutical sector. The move reflects the company's commitment to expanding its product pipeline and market access. With this acquisition, Senores Pharmaceuticals is poised for further growth in both regulated and emerging markets.
Quick answer
Senores Pharmaceuticals is acquiring Apnar Pharmaceuticals, announced August 30, 2026. Senores Pharmaceuticals is based in Copenhagen, Capital Region Of Denmark, Denmark.
- How much did Senores Pharmaceuticals pay for Apnar Pharmaceuticals?
- The deal value was not disclosed.
- What does Senores Pharmaceuticals do?
- Senores Pharmaceuticals is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and..
- Where are Senores Pharmaceuticals and Apnar Pharmaceuticals based?
- Senores Pharmaceuticals is based in Copenhagen, Capital Region Of Denmark, Denmark. Apnar Pharmaceuticals is based in Bahamas.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Petauri acquires Franklin Pharmaceutical Consulting (October 8, 2026)
- Lifecore Biomedical, Inc. Enters Merger Agreement with Lifecore Inc. (September 28, 2026)
- Lifecore Biomedical Announces Merger with Lifecore Inc. (September 27, 2026)
- Sun Pharma acquires Taro Pharmaceutical for $32.25/share (September 17, 2026)
- Abacus Medicine acquires Delfarma in Poland (September 15, 2026)
Who to call at Senores Pharmaceuticals, and when
When Senores Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Senores Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Senores Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Senores Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Senores Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Apnar Pharmaceuticals?
Apnar Pharmaceuticals was acquired by Senores Pharmaceuticals, based in Copenhagen. The deal was reported on August 30, 2026. Senores Pharmaceuticals is privately held and operates in Manufacturing.
When did Senores Pharmaceuticals acquire Apnar Pharmaceuticals?
Senores Pharmaceuticals's acquisition of Apnar Pharmaceuticals was reported on August 30, 2026. Senores Pharmaceuticals has completed Phase 1 of the acquisition of a 75% equity stake in Apnar Pharmaceuticals. This strategic acquisition aims to strengthen Senores' footprint in the pharmaceutical sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Apnar Pharmaceuticals do?
Apnar Pharmaceuticals is a pharmaceutical company known for its contributions to the healthcare sector. The company specializes in developing a variety of generic medications across multiple therapeutic areas. It is privately held, operating in Manufacturing, and is based in Bahamas.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.